Furthermore, preferentially expressed antigen of melanoma (PRAME), a type of Tumor associated antigens (TAA) gene, is overexpressed in CML-BP because of hypomethylation. Here, PRAME is linked to chronic myelogenous leukemia, BCR-ABL1 positive.